Clinical Trial to Evaluate the Efficacy and Safety of JPI-289 in Patients With Acute Ischemic Stroke
A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 110 participants.
Also called NCT03062397
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 110 participants
- Registry
-
NCT03062397
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Unknown status
Technical summary
Registry record NCT03062397. Randomized; quadruple masking; primary purpose treatment. Start 2016-12-09 (actual); primary completion 2020-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Trial to Evaluate the Efficacy and Safety of JPI-289 in Patients With Acute Ischemic Stroke
- Condition
- Acute Ischemic Stroke
- Intervention (Drug)
- JPI-289 Low-dose
- Intervention (Drug)
- JPI-289 High-dose
- Intervention (Drug)
- Placebo
- Lead sponsor
- Jeil Pharmaceutical Co., Ltd.
Record details
- Record id
cardio:ct-nct03062397- Content hash
ba439372bc263d01b74ea1047437c47ab0b4dab9dd5bee9a46a6926aeb674560